Immunomodulation by mucosal gene transfer using TGF-β DNA

Journal of Clinical Investigation

Volumn 102, Issue 2, 1998, Pages 438-444

  Kuklin, Nelly A ^a   Daheshia, Massoud ^a   Chun, Sangjun ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Gene transfer; Inflammation; Mucosal; Suppress; Therapeutic

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; IMMUNOMODULATION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL;

EID: 0032527923     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2803     Document Type: Article

References (26)

1. Manickan, E., K.L. Karem, and B.T. Rouse. 1997. DNA vaccines: a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17:139-154.
2. Daheshia, M., N. Kuklin, S. Kanangat, E. Manickan, and B.T. Rouse. 1997. Suppression of on-going ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. 159:1945-1952.
3. Neurath, M.F., I. Fuss, B.L. Kalsall, D.H. Presky, W. Waegell, and W. Stroher. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β mediated oral tolerance. J. Exp. Med. 183:2605-2616.
4. Marth, T., N. Strober, and B.L. Kelsall. 1996. High dose oral tolerance in ovalbumin TCR-transgenic mice systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J. Immunol. 157:2348-2357.
5. Weiner, H.L., A. Friedman, A. Miller, S.J. Khoury, A. Al-Sabagh, L. Santos, M. Savegh, R.B. Mussenblatt, D.E. Trentham, and D.A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animals and human organ specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
6. Santos, L.M., A. Al-Sabbagh, A. Londono, and H.L. Weiner. 1994. Oral tolerance by myelin basic protein induces regulatory TGF-β secreting cells in Peyer's patches by SJL mice. Cell. Immunol. 157:439-442.
7. Johns, L.D., K.C. Flanders, G.E. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β. J. Immunol. 147:1792-1796.
8. Li, Q., B. Sun, K. Dastgheib, and C. Chan. 1996. Suppressive effect of transforming growth factor β1 on the recurrence of experimental melanin protein-induced uveitis: up-regulation of ocular interleukin-10. Clin. Immunol. Immunol. 81:55-61.
9. Santambrogio, L., G.M. Hochwald, B. Saxena, C.H. Lev, J.E. Martz, J.A. Carlino, N.H. Ruddle, M.A. Palladino, L.I. Gold, and G.J. Thorbecke. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. Antagonism between TGF-β and tumor necrosis factor. J. Immunol. 151:1116-1127.
10. + T cells. J. Exp. Med. 183:2665-2674.
11. Spear, P.O., and B. Roizman. 1972. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J. Virol. 9:143-159.
12. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
13. + T cells. J. Virol. 69:4711-4716.
14. Kuklin, N., M. Daheshia, K. Karem, E. Manickan, and B.T. Rouse. 1997. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:3138-3145.
15. Nair, S., A.M.J. Buiting, R.J.D. Rouse, N. van Rooijen, L. Huang, and B.T. Rouse. 1995. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:679-688.
16. Slater, J.S., W.S. Futch, V.J. Cavanaugh, and A.E. Campbell. 1991. Murine cytomegalovirus independently inhibits priming of helper and cytotoxic T lymphocytes. Virology. 185:132-139.
17. Mohler, K.M., and L.D. Butler. 1989. In vitro detection of lymphokines produced by in vitro activated lymphocytes. J. Immunol. Methods. 121:67-73.
18. Rocha, B., and A. Bandiera. 1988. Limiting dilution analysis of interleukin-2 producing mature T cells. Scand. J. Immunol. 27:47-57.
19. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
20. Parr, M.B., L. Kepple, M.R. McDermott, M.D. Drew, J.J. Bozzola, and E.L. Parr. 1994. A mouse model lor studies of mucosal immunity to vaginal infection by herpes simplex type 2. Lab. Invest. 70:369-380.
21. Babu, J.S., S. Kanangat, and B.T. Rouse. 1995. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J. Immunol. 154:4822-1829.
22. Gould-Fogerite, S., and R.J. Mannino. 1996. Mucosal and systemic immunization using cochleate and liposome vaccines. J. Liposome Res. 6:357-379.
23. Kehrl, J.H., L.M. Wakefield, A.B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Dernyck, M.B. Sporn, and A.S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
24. Bootcov, M.R., A.R. Bauskin, S.M. Valenzuella, A.G. Moore, M. Bansal, X.Y. He, M.P. Zhang, M. Donnellan, S. Mahler, K. Pryor, et al. 1997. Mic-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA. 94:11514-11519.
25. D'orazio, T.J., and J.Y. Niederkorn. 1998. A novel role for TGF-β and IL-10 in induclion of immune privilege. J. Immunol. 160:2089-2098.
26. Maeda, H., H. Kuwahara, Y. Ichimura, M. Ohtsuki, S. Karakata, and A. Shiraishi. 1995. TGF-β enhances macrophages ability to produce IL-10 in normal and tumor bearing mice. J. Immunol. 155:4926-4932.